by Stacey Johnson | Nov 9, 2016
This isn’t the blog that I planned to write this week, but I’m so preoccupied with the outcome of the U.S. election, I’m finding it hard to focus on anything else right now. So, let’s look at the implications of a Trump presidency on science. An article in Nature...
by Lisa Willemse | Sep 30, 2016
There’s nothing really funny about the patent debate on CRISPR-Cas9 gene editing. It’s been a contentious and expensive court battle, that has thankfully steered clear of mud-slinging (mostly). Which is good, since there’s more than enough of that in the U.S. these...
by Holly Wobma | Sep 22, 2016
If you have been following stem cell news lately, you know that there have been several recent Food and Drug Administration (FDA) meetings regarding how to classify stem cells, which ultimately affects if and how they will be regulated. There are many medical...
by Stacey Johnson | Sep 16, 2016
September is Sepsis Awareness Month and World Sepsis Day was acknowledged earlier this week – on Tuesday, September 13. That’s why there’s a good possibility that you have seen the video below, about a heartbroken mother who lost her young son to sepsis. (It has...
by David Kent | Aug 2, 2016
Last week, a good friend of mine forwarded me a correspondence from the New England Journal of Medicine (NEJM). I was expecting to read about a new drug being tested in clinical trials or maybe a neat scientific perspective on leukemia biology, but what I got instead...
by Stacey Johnson | Jul 29, 2016
It was Science magazine’s 2013 breakthrough of the year and called a “turning point in cancer.” It even scored its own awareness month that year. Cancer immunotherapy – therapies that harness the power of a patient’s immune system to fight their disease – had...
Comments